Page last updated: 2024-10-22

amiodarone and B16 Melanoma

amiodarone has been researched along with B16 Melanoma in 2 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Bognar, Z2
Cseh, AM1
Fekete, K1
Antus, C1
Bognar, R2
Tapodi, A1
Ramadan, FHJ2
Sumegi, B1
Gallyas, F2
Szabo, A1
Kovacs, D1
Takatsy, A1

Other Studies

2 other studies available for amiodarone and B16 Melanoma

ArticleYear
Amiodarone's major metabolite, desethylamiodarone inhibits proliferation of B16-F10 melanoma cells and limits lung metastasis formation in an in vivo experimental model.
    PloS one, 2020, Volume: 15, Issue:9

    Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cel

2020
Involvement of Mitochondrial Mechanisms in the Cytostatic Effect of Desethylamiodarone in B16F10 Melanoma Cells.
    International journal of molecular sciences, 2020, Oct-05, Volume: 21, Issue:19

    Topics: Amiodarone; Animals; Apoptosis; Apoptosis Inducing Factor; Cell Proliferation; Cytochromes c; Cytost

2020